Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Xu, Gui Fang ^a   Zhang, Wei Jie ^a   Sun, Qi ^a   Xu, Xinyun ^a   Zou, Xiaoping ^a   Guan, Wenxian ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD44V ANTIGEN; PROTEIN; SNAIL 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZEB 1 PROTEIN;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER STEM CELL; CANCER SURGERY; CONTROLLED STUDY; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREOPERATIVE EVALUATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; RADICAL RESECTION; STOMACH CANCER; SURVIVAL TIME; TUMOR VOLUME; ADULT; CHINA; DIAGNOSIS; ENZYME IMMUNOASSAY; EPIDEMIOLOGY; GASTRECTOMY; INCIDENCE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PERITONEAL NEOPLASMS; PROGNOSIS; SECONDARY; STOMACH NEOPLASMS; SURVIVAL RATE; TISSUE MICROARRAY; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CHINA; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; PERITONEAL NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS;

EID: 84924722369     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-368     Document Type: Article

References (16)

1. Steinestel K, Eder S, Schrader AJ, Steinestel J: Clinical significance of epithelial-mesenchymal transition. Clin Transl Med 2014, 3:17. 10.1186/2001-1326-3-17
2. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC: Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27:1006-1020. 10.1002/stem.30
3. Chen T, Yang K, Yu J, Meng W, Yuan D, Bi F, Meng W, Yuan D, Bi F, Liu F, Liu J, Dai B, Chen X, Wang F, Zeng F, Xu H, Hu J, Mo X: Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res 2012, 22:248-258. 10.1038/cr.2011.109
4. Stojnev S, Krstic M, Ristic-Petrovic A, Stefanovic V, Hattori T: Gastric cancer stem cells: therapeutic targets. Gastric Cancer 2014, 17:13-25. 10.1007/s10120-013-0254-x
5. Ryu HS, Park Do J, Kim HH, Kim WH, Lee HS: Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol 2012, 43:520-528. 10.1016/j.humpath.2011.07.003
6. Edge SB, Byrd DR, Carolyn CC, Fritz AG, Greene FL, Trotti A (Eds): AJCC Cancer Staging Manual. 7th edition. Chicago, IL: Springer; 2010:117-126.
7. Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Liu CL, van de Rijn M, Gilks CB: Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 2002, 15:1374-1380. 10.1097/01.MP.0000039571.02827.CE
8. Li F, Zhang R, Liang H, Liu H, Quan J: The pattern and risk factors of recurrence of proximal gastric cancer after curative resection. J Surg Oncol 2013, 107:130-135. 10.1002/jso.23252
9. Otsuji E, Kuriu Y, Ichikawa D, Okamoto K, Ochiai T, Hagiwara A, Yamagishi H: Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World J Surg 2004, 28:866-869. 10.1007/s00268-004-7359-7
10. Eom BW, Yoon H, Ryu KW, Lee JH, Cho SJ, Lee JY, Kim CG, Choi IJ, Lee JS, Kook MC, Park SR, Nam BH, Kim YW: Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg 2010, 27:481-486. 10.1159/000320691
11. Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, Li R, Zhao QD, Yang Y, Lu ZH, Wei LX: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett 2014, 352:160-168. 10.1016/j.canlet.2014.05.008
12. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting micro-RNAs. Nat Cell Biol 2009, 11:1487-1195. 10.1038/ncb1998
13. Chen S, Hou JH, Feng XY, Zhang XS, Zhou ZW, Yun JP, Chen YB, Cai MY: Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. J Surg Oncol 2013, 107:799-806. 10.1002/jso.23337
14. Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W: Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int 2012, 62:112-119. 10.1111/j.1440-1827.2011.02760.x
15. Chiang CY, Huang KH, Fang WL, Wu CW, Chen JH, Lo SS, Hsieh MC, Shen KH, Li AF, Niu DM, Chiou SH: Factors associated with recurrence within 2 years after curative surgery for gastric adenocarcinoma. World J Surg 2011, 35:2472-2478. 10.1007/s00268-011-1247-8
16. Wu J, Liu X, Cai H, Wang Y: Prediction of tumor recurrence after curative resection in gastric carcinoma based on bcl-2 expression. World J Surg Oncol 2014, 12:40. 10.1186/1477-7819-12-40